RBS Global Big Pharma ETN (DRGS)

  • Loading...

Fund Description

The investment seeks to replicate, net of expenses, the NYSE Arca Equal Weighted Pharmaceutical Total Return Index. The index is designed to track the performance of the equity securities of a cross section of companies involved in various phases of development, production and marketing of pharmaceuticals, with the component securities represented in approximately equal dollar amounts.

Fund Snapshot Updated 07.10.2014

Previous Close $48.86 Expense Ratio 0.60%
YTD Return 21.05% Avg. 30-Day Volume 2,237
1-Year Return 42.7% Market Cap Loading...
Bid $48.48 Shares Outstanding 160,000
Ask $49.94 Dividends $0.00

Best Fit Health/Biotechnology Funds

See full rankings for Health/Biotechnology Funds